Ganaxolone Safety Profile in CDKL5 Deficiency Disorder: Results From a Phase 3 Randomized, Double-blind, Placebo-Controlled Trial

被引：0
|
作者：
Pestana-Knight, E.
Rybak, E.
Grachev, I
Miller, I
机构：
来源：
ANNALS OF NEUROLOGY | 2021年 / 90卷
关键词：
Epilepsy;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
244
引用
收藏
页码：S132 / S133
页数：2
相关论文
共 50 条
  • [41] SAGE-217 in major depressive disorder: A phase 3, multicenter, double-blind, randomized, placebo-controlled trial
    Clayton, A.
    Lasser, R.
    Nandy, I.
    Sankoh, A.
    Campbell, D.
    Werneburg, B.
    Silber, C.
    Jonas, J.
    Kanes, S.
    Gunduz-Bruce, H.
    EUROPEAN PSYCHIATRY, 2020, 63 : S24 - S25
  • [42] SAGE-217 in Major Depressive Disorder: A Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
    Mittal, Akanksha
    Clayton, Anita
    Lasser, Robert
    Nandy, Indrani
    Sankoh, Abdul
    Campbell, Andrew
    Werneburg, Brian
    Silber, Christopher
    Jonas, Jeff
    Kanes, Steve
    Gunduz-Bruce, Handan
    NEUROLOGY, 2020, 94 (15)
  • [43] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [44] A double-blind placebo-controlled trial of risperidone in autistic disorder
    McDougle, C
    Aman, MG
    McCracken, JT
    Scahill, L
    Tierney, E
    Vitiello, B
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S327 - S328
  • [45] Double-blind, placebo-controlled trial of venlafaxine for panic disorder
    Pollack, MH
    Worthington, JJ
    Otto, MW
    Smoller, JW
    Maki, KM
    Rudolph, R
    Rosenbaum, JF
    PSYCHOPHARMACOLOGY BULLETIN, 1996, 32 (03) : 496 - 496
  • [46] Efficacy and Safety of Pregabalin for Fibromyalgia in a Population of Chinese Patients: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial
    Zhang, Xiao
    Xu, Huji
    Zhang, Zhiyi
    Li, Yang
    Pauer, Lynne
    Liao, Shanmei
    Xu, Gaiping
    Zhang, Fengchun
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [47] EFFICACY AND SAFETY OF BARICITINIB IN PATIENTS WITH ACTIVE LUPUS NEPHRITIS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIAL
    Hassanien, M.
    Moshrif, A.
    Hetta, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 34 - 35
  • [48] A randomized, double-blind, placebo-controlled trial of quetiapine in bipolar disorder and alcohol dependence
    Brown, E. S.
    Garza, M.
    Carmody, T.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2007, 31 (06) : 59A - 59A
  • [49] Marfan Sartan: a randomized, double-blind, placebo-controlled trial
    Milleron, Olivier
    Arnoult, Florence
    Ropers, Jacques
    Aegerter, Philippe
    Detaint, Delphine
    Delorme, Gabriel
    Attias, David
    Tubach, Florence
    Dupuis-Girod, Sophie
    Plauchu, Henry
    Barthelet, Martine
    Sassolas, Francois
    Pangaud, Nicolas
    Naudion, Sophie
    Thomas-Chabaneix, Julie
    Dulac, Yves
    Edouard, Thomas
    Wolf, Jean-Eric
    Faivre, Laurence
    Odent, Sylvie
    Basquin, Adeline
    Habib, Gilbert
    Collignon, Patrick
    Boileau, Catherine
    Jondeau, Guillaume
    EUROPEAN HEART JOURNAL, 2015, 36 (32) : 2160 - U37
  • [50] A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline in Patients with Alcohol Use Disorder
    Brown, E. Sherwood
    Van Enkevort, Erin
    Kulikova, Alexandra
    Escalante, Chastity
    Nakamura, Alyson
    Ivleva, Elena I.
    Holmes, Traci
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2019, 43 (02): : 317 - 323
12345